PMGC Holdings’ Northstrive Biosciences Announces Results From Phase III Of AI-Driven Drug Discovery Program With Strategic Partner Yuva Bios
Yuva Biosciences' proprietary MitoNova™ AI platform identified small-molecule candidates that were biologically validated in primary human skeletal muscle cells, with multiple candidates increasing ANT1, a mitochondrial protein central to skeletal muscle energy metabolism. Four AI-selected compounds demonstrated ANT1 i